ATE195526T1 - Verfahren zur herstellung von epirubicin oder zusatzsalzen davon, von daunorubicin - Google Patents

Verfahren zur herstellung von epirubicin oder zusatzsalzen davon, von daunorubicin

Info

Publication number
ATE195526T1
ATE195526T1 AT96203554T AT96203554T ATE195526T1 AT E195526 T1 ATE195526 T1 AT E195526T1 AT 96203554 T AT96203554 T AT 96203554T AT 96203554 T AT96203554 T AT 96203554T AT E195526 T1 ATE195526 T1 AT E195526T1
Authority
AT
Austria
Prior art keywords
daunosamine
daunomycinone
daunorubicin
group
converted
Prior art date
Application number
AT96203554T
Other languages
English (en)
Inventor
Der Rijst Marcel Van
Johan Wilhelm Scheeren
Vos Dick De
Original Assignee
Pharmachemie Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmachemie Bv filed Critical Pharmachemie Bv
Application granted granted Critical
Publication of ATE195526T1 publication Critical patent/ATE195526T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/24Condensed ring systems having three or more rings
    • C07H15/252Naphthacene radicals, e.g. daunomycins, adriamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT96203554T 1996-12-16 1996-12-16 Verfahren zur herstellung von epirubicin oder zusatzsalzen davon, von daunorubicin ATE195526T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96203554A EP0848009B1 (de) 1996-12-16 1996-12-16 Verfahren zur Herstellung von Epirubicin oder Zusatzsalzen davon, von Daunorubicin

Publications (1)

Publication Number Publication Date
ATE195526T1 true ATE195526T1 (de) 2000-09-15

Family

ID=8224702

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96203554T ATE195526T1 (de) 1996-12-16 1996-12-16 Verfahren zur herstellung von epirubicin oder zusatzsalzen davon, von daunorubicin

Country Status (11)

Country Link
US (1) US5874550A (de)
EP (1) EP0848009B1 (de)
JP (1) JP4176845B2 (de)
AT (1) ATE195526T1 (de)
CA (1) CA2224764C (de)
DE (1) DE69609845T2 (de)
DK (1) DK0848009T3 (de)
ES (1) ES2151632T3 (de)
GR (1) GR3034608T3 (de)
PT (1) PT848009E (de)
SI (1) SI0848009T1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100785966B1 (ko) * 2000-08-10 2007-12-14 동아제약주식회사 안트라싸이클린계 항암제인 에피루비신 및 약학적으로허용되는 그 염의 제조방법
KR100850408B1 (ko) * 2000-08-10 2008-08-04 동아제약주식회사 안트라싸이클린계 항암제인 에피루비신 및 약학적으로허용되는 그 염의 제조방법
CN100412084C (zh) * 2003-07-02 2008-08-20 獀洛克斯股份有限公司 热稳定的结晶盐酸表柔比星及其制造方法
US20090099346A1 (en) * 2003-07-02 2009-04-16 Victor Matvienko Thermally stable crystalline epirubicin hydrochloride
US7388083B2 (en) * 2005-03-07 2008-06-17 Solux Corporation Epimerization of 4′-C bond and modification of 14-CH3-(CO)-fragment in anthracyclin antibiotics
WO2006111561A1 (en) * 2005-04-21 2006-10-26 Dsm Ip Assets B.V. Improved microbial production of anthracyclins
DE06848583T1 (de) 2005-12-13 2011-03-17 Solux Corporation, San Diego Verfahren zur herstellung von 4-demethyldaunorubicin
US8802830B2 (en) * 2005-12-20 2014-08-12 Solux Corporation Synthesis of epirubicin from 13-dihydrodaunorubicine
EP1990405B1 (de) * 2007-05-08 2017-07-26 Provivo Oy Genetisch modifizierte Stämme zur Produktion von Anthracyclin-Metaboliten, die als Krebsheilmittel dienen können
US8357785B2 (en) * 2008-01-08 2013-01-22 Solux Corporation Method of aralkylation of 4′-hydroxyl group of anthracylins
WO2010028667A1 (en) * 2008-09-11 2010-03-18 W.C. Heraeus Gmbh Genetically modified strains for biotransformations in anthracycline production
PL2301943T3 (pl) 2009-09-08 2014-06-30 Heraeus Precious Metals Gmbh Krystalizacja epidaunorubicyny x HCI
KR101125460B1 (ko) 2010-03-24 2012-03-28 동아제약주식회사 에피루비신 염산염의 신규한 결정형
DE102011103751A1 (de) 2011-05-31 2012-12-06 Heraeus Precious Metals Gmbh & Co. Kg Kristallisierung von Epirubicinhydrochlorid
DE102011111991A1 (de) * 2011-08-30 2013-02-28 Lead Discovery Center Gmbh Neue Cyclosporin-Derivate
US9963479B2 (en) 2013-07-02 2018-05-08 Zhejiang Hisun Pharmaceutical Co., Ltd. Method for preparing epirubicin and intermediate thereof
TWI712611B (zh) 2015-03-30 2020-12-11 日商明治製菓藥業股份有限公司 泛艾黴素之製造方法及其新穎之製造中間體
CN104861014B (zh) * 2015-06-03 2017-09-29 道中道(菏泽)制药有限公司 一种盐酸表阿霉素结晶的制备方法
WO2017120729A1 (zh) * 2016-01-11 2017-07-20 浙江海正药业股份有限公司 一种盐酸表柔比星的制备方法及其中间体
CN112574267A (zh) * 2019-09-28 2021-03-30 鲁南制药集团股份有限公司 一种盐酸表柔比星中间体化合物iii
CN114149473B (zh) * 2020-09-08 2024-03-15 鲁南制药集团股份有限公司 一种盐酸表柔比星的合成方法及其中间体

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3803124A (en) 1968-04-12 1974-04-09 Farmaceutici It Soc Process for the preparation of adriamycin and adriamycinone and adriamycin derivatives
GB1457632A (en) 1974-03-22 1976-12-08 Farmaceutici Italia Adriamycins
FI860683A7 (fi) 1984-06-14 1986-02-14 Biogal Gyogyszergyar Menetelmä adriamysiinin ja sen halidisuolojen valmistamiseksi.
GB8519452D0 (en) * 1985-08-02 1985-09-11 Erba Farmitalia Injectable solutions
IT1196503B (it) 1986-07-16 1988-11-16 Erba Farmitalia Procedimento continuo per la trasformazione di 4'-cheto-n-trifluoroacetildaunorubicina in 4'-epi-trifluoroacetildaunorubicina,internmedio per la preparazione di un composto
IT1230505B (it) * 1988-10-11 1991-10-25 Sicor Spa Procedimento per la conversione della daunorubicina in doxorubicina.
IT1275953B1 (it) * 1995-03-22 1997-10-24 Sicor Spa Procedimento per la preparazione di antibiotici della classe delle antracicline

Also Published As

Publication number Publication date
CA2224764C (en) 2006-10-03
DK0848009T3 (da) 2000-11-20
ES2151632T3 (es) 2001-01-01
CA2224764A1 (en) 1998-06-16
EP0848009A1 (de) 1998-06-17
JP4176845B2 (ja) 2008-11-05
SI0848009T1 (en) 2000-12-31
PT848009E (pt) 2000-11-30
DE69609845D1 (de) 2000-09-21
JPH10175991A (ja) 1998-06-30
DE69609845T2 (de) 2000-12-21
GR3034608T3 (en) 2001-01-31
US5874550A (en) 1999-02-23
EP0848009B1 (de) 2000-08-16

Similar Documents

Publication Publication Date Title
ATE195526T1 (de) Verfahren zur herstellung von epirubicin oder zusatzsalzen davon, von daunorubicin
DE69713374D1 (de) Verfahren zur herstellung von optisch reinen isomeren des formoterols
EP0132732A3 (en) Homologues from aprotinine whose lys 15 amino acid is substituted by other amino acids, process for their preparation and their use as medicaments
ATE331031T1 (de) Peptidfragment des g-proteins des respiratorischen syncytialvirus, immunogene verbindung und pharmazeutische zusammensetzung, die es enthalten, und herstellungsverfahren
DE69020794D1 (de) Enzymatische Entfernung einer aminoterminalen Proteinsequenz.
ATE48278T1 (de) Verfahren zur herstellung von 2'desoxyadenosinverbindungen.
PT81528B (pt) Processo para a sintese de peptideos
ATE60308T1 (de) Verfahren zur herstellung fester aluminiumchlorid-zusammensetzungen.
ES2144698T3 (es) Procedimiento para preparar un derivado de biciclohexano.
ATE209213T1 (de) Herstellung von gereinigten (poly)peptiden
DK0524143T3 (da) Fremgangsmåde til fremstilling af aktiverede sialinsyrer
PT98700A (pt) Processo para a preparacao de acidos aminometanofosfonico e de acidos aminometil-fosfinicos
MA21305A1 (fr) Procede de preparation de l'acide (pyridyl-3)-3 ih,3h-pyrrono(i,2-c) thiazolecarboxylique-7 dextrocyre.
DE3750117D1 (de) Verfahren zur Herstellung von Indolinon-2-Derivaten.
ATE99323T1 (de) Verfahren zur wiedergewinnung eines gereinigten epi-proteins aus einer loesung, insbesondere einer gaerungsloesung.
DE69404560D1 (de) Verfahren zur Herstellung von kristallisiertem Loracarbef Monohydrat
AU590659B2 (en) Process for producing l-amino acids or 5'-inosinic acid by fermentation
ATE93845T1 (de) Verfahren zur herstellung von 4,4'-bis-(4aminophenoxy)-diphenylsulfon.
DE69720432D1 (de) Verfahren zur herstellung von 2-hydroxynaphtalin-3,6-dicarbonsaure
ATE125526T1 (de) Verfahren zur herstellung von 2-chlor-4- fluorphenol.
DE69010415D1 (de) Verfahren zur Herstellung eines Yttriumoxysulfid-Phosphors.
DE69015797D1 (de) Verfahren zur herstellung von 3,4,3',4'-substituierten biphenylverbindungen.
ATE33384T1 (de) Verfahren zur herstellung eines 1,5-geschuetzten 1,5,10-triazadecans, zwischenprodukte hierfuer und deren herstellung.
BG51403A1 (en) Oligomer amonium salts of bromonitrosulphonic acids and method for their preparation
JPS5528964A (en) Method of removing protecting group from protected peptide

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee